SCHEMBL2286903

SCHEMBL2286903

CNCC1CCN(CCOC)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 4/20 0.40
PRMT6 Q96LA8 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPK1 P28482 1/20 0.39
LTA4H P09960 1/20 0.38
LIPG Q9Y5X9 1/20 0.36
KDM1A O60341 1/20 0.36
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
GBA1 P04062 1/20 0.35
GSK3B P49841 4/20 0.34
PRMT1 Q99873 1/20 0.34
PRMT8 Q9NR22 1/20 0.34
KAT2B Q92831 1/20 0.34
PIM1 P11309 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14488004 0.89 L3MBTL1 (0.49) CARM1PRMT6L3MBTL1LIPGKDM1A
SCHEMBL14768525 0.85 GBA1 (0.42) L3MBTL1KDM1AGBA1KCNH2
SCHEMBL23205833 0.82 ALDH1A1 (0.39) CARM1PRMT6MEN1KMT2AMAPK1
SCHEMBL21456311 0.81 CARM1 (0.39) CARM1PRMT6MEN1KMT2AKAT2B
SCHEMBL18082565 0.80 GBA1 (0.38) CARM1PRMT6MEN1KMT2AMAPK1
SCHEMBL12458880 0.80 GBA1 (0.38) CARM1PRMT6MEN1KMT2AMAPK1
SCHEMBL1999164 0.79 GBA1 (0.47) MEN1KMT2AMAPK1LTA4HKDM1A
SCHEMBL11972716 0.79 NCF1 (0.45) CARM1PRMT6MEN1KMT2AMAPK1
SCHEMBL12374980 0.77 GBA1 (0.36) CARM1PRMT6MEN1KMT2AMAPK1
SCHEMBL12563475 0.76 ALDH1A1 (0.35) CARM1PRMT6MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536716-B1 AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-05-21 EP disclosed
US-8426604-B2 Aminothiazolones as estrogen related receptor-alpha modulators JANSSEN PHARMACEUTICA NV (BE) 2013-04-23 US disclosed
EP-2536716-A1 AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS Janssen Pharmaceutica, N.V. (BE) 2012-12-26 EP disclosed
WO-2011103130-A1 AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-08-25 WO disclosed
US-20110200586-A1 AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200586-A1 AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS ESR2, ESRRA, ESRRG CARM1 1395/4885PRMT6 1075/4885L3MBTL1 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.